Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 32.78
-0.94 (-2.79%)
Aug 3, 2026, 1:42 PM CET
Nanobiotix Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 52.75 | 49.74 | 75.28 | 41.39 | 83.92 |
Cash & Short-Term Investments | 52.75 | 49.74 | 75.28 | 41.39 | 83.92 |
Cash Growth | 6.06% | -33.93% | 81.90% | -50.68% | -29.57% |
Accounts Receivable | 2.14 | 2.98 | 2.97 | 0.1 | - |
Other Receivables | 5.55 | 5.56 | 5.43 | 5.19 | 3.93 |
Receivables | 7.68 | 8.54 | 8.4 | 5.29 | 3.93 |
Prepaid Expenses | 2.32 | 3.2 | 2.56 | 2.98 | 2.21 |
Other Current Assets | 0 | -0 | 1.1 | 2.7 | 3 |
Total Current Assets | 62.75 | 61.47 | 87.34 | 52.36 | 93.06 |
Property, Plant & Equipment | 4.17 | 5.29 | 6.11 | 7.12 | 8.19 |
Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0 | 0 |
Other Long-Term Assets | 0.83 | 0.66 | 0.44 | 0.29 | 0.52 |
Total Assets | 67.76 | 67.42 | 93.9 | 59.77 | 101.77 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.58 | 4.48 | 6.7 | 4 | 5 |
Accrued Expenses | 9.14 | 21.89 | 18.3 | 11.63 | 6.31 |
Current Portion of Long-Term Debt | 3.1 | 3.66 | 3.82 | 3.6 | 7.08 |
Current Portion of Leases | 1.21 | 1.26 | 1.2 | 0.96 | 1.13 |
Current Income Taxes Payable | 0.22 | 0.54 | 0.45 | 0.36 | 0.26 |
Current Unearned Revenue | 36.22 | 18.16 | 18.23 | 16.57 | 16.77 |
Other Current Liabilities | 1.04 | 8.94 | 1.18 | 0.82 | 0.31 |
Total Current Liabilities | 57.51 | 58.94 | 49.87 | 37.94 | 36.85 |
Long-Term Debt | 89.12 | 43.01 | 41.66 | 44.04 | 32.42 |
Long-Term Leases | 1.89 | 2.97 | 3.88 | 4.57 | 5.39 |
Pension & Post-Retirement Benefits | 0.51 | 0.43 | 0.32 | 0.27 | 0.32 |
Other Long-Term Liabilities | 3.22 | 27.78 | 0 | - | - |
Total Liabilities | 152.24 | 133.12 | 95.74 | 86.81 | 74.98 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.45 | 1.42 | 1.41 | 1.05 | 1.05 |
Additional Paid-In Capital | 314.4 | 312.74 | 312.74 | 255.76 | 255.77 |
Retained Earnings | -23.96 | -68.13 | -39.7 | -57.04 | -47 |
Treasury Stock | -0.23 | -0.23 | -0.23 | -0.23 | -0.2 |
Comprehensive Income & Other | -376.15 | -311.51 | -276.07 | -226.58 | -182.82 |
Shareholders' Equity | -84.48 | -65.7 | -1.84 | -27.05 | 26.79 |
Total Liabilities & Equity | 67.76 | 67.42 | 93.9 | 59.77 | 101.77 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 95.32 | 50.9 | 50.57 | 53.17 | 46.02 |
Net Cash (Debt) | -42.57 | -1.17 | 24.72 | -11.78 | 37.9 |
Net Cash Growth | - | - | - | - | -45.99% |
Net Cash Per Share | -0.89 | -0.02 | 0.67 | -0.34 | 1.09 |
Filing Date Shares Outstanding | 48.39 | 47.4 | 47.11 | 34.85 | 34.81 |
Total Common Shares Outstanding | 48.39 | 47.4 | 47.11 | 34.85 | 34.81 |
Working Capital | 5.24 | 2.53 | 37.47 | 14.42 | 56.22 |
Book Value Per Share | -1.75 | -1.39 | -0.04 | -0.78 | 0.77 |
Tangible Book Value | -84.49 | -65.71 | -1.85 | -27.05 | 26.79 |
Tangible Book Value Per Share | -1.75 | -1.39 | -0.04 | -0.78 | 0.77 |
Machinery | 7.3 | 7.14 | 6.73 | 6.49 | 6.5 |
Construction In Progress | 0.25 | 0.14 | 0.04 | 0.34 | 0.1 |